This study will evaluate the study medication’s effectiveness in treating moderate to severe asthma Gender: Male and Females Age: 18 Years+ Compensation: Up to $1920 Study Eligibility: ● Must have Physician-diagnosed moderate-to-severe asthma for ≥12 months ● Must have ≥1 asthma exacerbation in the past year ● Must have Body mass index (BMI) within the range 18.5 to 40 kg/m2 (inclusive). ● Cannot have Chronic obstructive or other significant lung diseases (eg, COPD [chronic obstructive pulmonary disease], idiopathic pulmonary fibrosis, etc) which may impair lung function, or another diagnosed pulmonary or systemic disease. ● Cannot have Known history of significant immunosuppression or suspected current significant immunosuppression. ● Cannot have any malignancies (excluding basal and squamous cell skin cancer and in situ cervical carcinoma that has been excised and cured >3 years ago. ● Cannot have history of solid organ transplant ● Cannot have HIV
TEXT THE VAST CLINICAL RESEARCH TEAM 972- 503-9388 | 